We are happy to announce our collaboration with Poietis, a company with headquarters in Bordeaux, France. Together with Poietis our mission is to provide solutions leveraging a proprietary, innovative Next-Generation Bioprinting platform and bring Tissue Engineering therapies to patients.

‍
Poietis is a spin-off from INSERM and University of Bordeaux where Laser-Assisted Bioprinting Technology was initially developed. On the basis of its expertise in high resolution Laser-Assisted Bioprinting (LAB), Poietis has developed the Next-Generation Bioprinting (NGB) platform.